melatonin has been researched along with atenolol in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.88) | 18.7374 |
| 1990's | 10 (31.25) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Cagnacci, A; Elliott, JA; Yen, SS | 1 |
| Blumhofer, A; Demisch, L; Gebhart, P; Khazai, A; Lemmer, B; Sielaff, T | 1 |
| James, SP; Parry, BL; Rosenthal, NE; Wehr, TA | 1 |
| Demitrack, MA; Lewy, AJ; Reus, VI | 1 |
| Brismar, K; Mogensen, L; Wetterberg, L | 1 |
| Arendt, J; Jacobsen, FM; James, SP; Parry, BL; Rosenthal, NE; Sack, DA; Wehr, TA | 1 |
| Brismar, K; Eliasson, K; Hylander, B; Rössner, S; Wetterberg, L | 1 |
| Parry, BL; Rosenthal, NE; Tamarkin, L; Wehr, TA | 1 |
| Lewy, AJ; Sack, RL | 1 |
| Arendt, J; Bojkowski, C; Franey, C; Marks, V; Wright, J | 1 |
| Cowen, PJ; Fraser, S; Green, AR; Sammons, R | 1 |
| Cagnacci, A; Romagnolo, C; Soldani, R; Yen, SS | 1 |
| Dawson, D; Reid, KJ; Van Den Heuvel, CJ | 1 |
| Burrows, GD; Maguire, KP; Nathan, PJ; Norman, TR | 1 |
| Forsling, ML; Yasin, SA | 1 |
| Arendt, J; Deacon, S; English, J; Tate, J | 1 |
| Lercher, P; Liebmann, P; Lindner, W; Maier, R; Sakotnik, A; Stoschitzky, K; Zweiker, R | 1 |
| Enzminger, H; Lemmer, B; Witte, K | 1 |
| Paparrigopoulos, T | 1 |
| Celbiş, O; Mizrak, B; Olmez, E; Parlakpinar, H | 1 |
| Beitelshees, AL; Chang, SW; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Langaee, TY; McDonough, CW; Nasiri Kenari, N; Turner, ST | 1 |
1 review(s) available for melatonin and atenolol
| Article | Year |
|---|---|
Light therapy and psychiatry.
Topics: Atenolol; Circadian Rhythm; Depression; Depressive Disorder; Humans; Light; Melatonin; Mental Disorders; Periodicity; Phototherapy; Pineal Gland; Seasons; Sleep; Sleep Deprivation; Suprachiasmatic Nucleus; Time Factors | 1986 |
11 trial(s) available for melatonin and atenolol
| Article | Year |
|---|---|
Melatonin: a major regulator of the circadian rhythm of core temperature in humans.
Topics: Adult; Atenolol; Body Temperature; Body Temperature Regulation; Circadian Rhythm; Female; Humans; Melatonin; Placebos | 1992 |
Atenolol in premenstrual syndrome: a test of the melatonin hypothesis.
Topics: Affect; Atenolol; Female; Humans; Melatonin; Premenstrual Syndrome; Psychiatric Status Rating Scales; Sleep | 1991 |
Atenolol in seasonal affective disorder: a test of the melatonin hypothesis.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Melatonin; Phototherapy; Placebos; Pulse; Seasons; Secretory Rate | 1988 |
Melatonin secretion related to side-effects of beta-blockers from the central nervous system.
Topics: Adult; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Melatonin; Propranolol; Prospective Studies; Random Allocation; Sleep Wake Disorders | 1988 |
Treatment of a patient with seasonal premenstrual syndrome.
Topics: Adult; Atenolol; Clinical Trials as Topic; Female; Hospitalization; Humans; Melatonin; Phototherapy; Premenstrual Syndrome; Propranolol; Seasons | 1987 |
Melatonin-induced decrease of body temperature in women: a threshold event.
Topics: Adult; Atenolol; Body Temperature; Circadian Rhythm; Double-Blind Method; Female; Follicular Phase; Humans; Melatonin; Placebos | 1994 |
Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin.
Topics: Adult; Atenolol; Body Temperature; Double-Blind Method; Humans; Male; Melatonin; Sleep | 1997 |
The effect of atenolol, a beta1-adrenergic antagonist, on nocturnal plasma melatonin secretion: evidence for a dose-response relationship in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Dose-Response Relationship, Drug; Female; Humans; Male; Melatonin; Pineal Gland; Radioimmunoassay; Receptors, Adrenergic, beta-1; Single-Blind Method | 1997 |
Atenolol facilitates light-induced phase shifts in humans.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Humans; Male; Melatonin; Photic Stimulation; Random Allocation; Saliva | 1998 |
Influence of beta-blockers on melatonin release.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbazoles; Carvedilol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Male; Melatonin; Propanolamines; Propranolol; Stereoisomerism; Verapamil | 1999 |
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
Topics: Atenolol; Blood Glucose; Fasting; Female; Glucose; Humans; Male; Melatonin; Middle Aged; Polymorphism, Single Nucleotide; Protein Kinase C beta; Signal Transduction; White People | 2016 |
20 other study(ies) available for melatonin and atenolol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase | 2011 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Chronobiological effects of L-tryptophan in humans: influence on melatonin secretion.
Topics: Acetylserotonin O-Methyltransferase; Adult; Arylamine N-Acetyltransferase; Atenolol; Circadian Rhythm; Female; Humans; Infusions, Intravenous; Male; Melatonin; Pineal Gland; Receptors, Adrenergic, beta; Secretory Rate; Serotonin; Stimulation, Chemical; Tryptophan | 1991 |
Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion.
Topics: Adult; Atenolol; Circadian Rhythm; Female; Humans; Hypothalamo-Hypophyseal System; Male; Melatonin; Pineal Gland; Pituitary-Adrenal System; Propranolol | 1990 |
Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Atenolol; Dreams; Female; Hallucinations; Humans; Male; Melatonin; Metoprolol; Middle Aged; Propranolol | 1987 |
Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol.
Topics: Animals; Antibodies; Atenolol; Chromatography, Paper; Circadian Rhythm; Cross Reactions; Female; Humans; Immunoassay; Liver; Melatonin; Rats; Rats, Inbred Strains | 1985 |
Atenolol reduces plasma melatonin concentration in man.
Topics: Adult; Atenolol; Depression, Chemical; Female; Humans; Male; Melatonin; Propanolamines | 1983 |
Mechanisms of melatonin inhibition of neurohypophysial hormone release from the rat hypothalamus in vitro.
Topics: Animals; Atenolol; Atropine; Haloperidol; Hypothalamus; Ibuprofen; In Vitro Techniques; Male; Mecamylamine; Melatonin; Naloxone; Oxytocin; Phentolamine; Rats; Rats, Wistar; Receptors, Neurotransmitter; Reproducibility of Results; Vasopressins | 1998 |
Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Angiotensin II; Animals; Animals, Genetically Modified; Atenolol; Cells, Cultured; Dose-Response Relationship, Drug; Isoproterenol; Male; Melatonin; Norepinephrine; Pineal Gland; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 2001 |
Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Case-Control Studies; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Melatonin; Middle Aged; Receptors, Adrenergic, beta; Severity of Illness Index | 2002 |
Effect of melatonin and atenolol on carbon monoxide cardiotoxicity: an experimental study in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carbon Monoxide Poisoning; Carboxyhemoglobin; Female; Heart Rate; Melatonin; Myocardial Contraction; Myocardium; Necrosis; Rats; Rats, Sprague-Dawley | 2006 |